COMPASSIONATE USE TRIPLE THERAPY CFTR MODULATION (KAFTRIO) IN SEVERE DISEASE. SINGLE-CENTRE REAL WORLD CLINICAL OUTCOMES, SAFETY AND TOLERABILITY